Centogene Future Growth
Future criteria checks 1/6
Centogene's earnings are forecast to decline at 5.7% per annum while its annual revenue is expected to grow at 12.4% per year. EPS is expected to grow by 27.4% per annum.
Key information
-5.7%
Earnings growth rate
27.4%
EPS growth rate
Healthcare earnings growth | 15.9% |
Revenue growth rate | 12.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 19 Jan 2024 |
Recent future growth updates
Recent updates
Centogene N.V.'s (NASDAQ:CNTG) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors
Feb 16Centogene N.V. (NASDAQ:CNTG) Might Not Be As Mispriced As It Looks
Dec 21Centogene GAAP EPS of -€0.28, revenue of €10.32M
Jul 15Is Centogene (NASDAQ:CNTG) Using Debt In A Risky Way?
Nov 25Is Centogene (NASDAQ:CNTG) Using Debt Sensibly?
Jun 29Centogene reports Q1 results
Jun 16Centogene, Alector initiate EFRONT study in frontotemporal dementia
Jun 02Centogene to nominate Rene Just as CFO at the upcoming Annual General Meeting
May 26Need To Know: Analysts Are Much More Bullish On Centogene N.V. (NASDAQ:CNTG)
Apr 17What Percentage Of Centogene N.V. (NASDAQ:CNTG) Shares Do Insiders Own?
Mar 05Update: Centogene (NASDAQ:CNTG) Stock Gained 11% In The Last Year
Jan 29Is Centogene (NASDAQ:CNTG) A Risky Investment?
Dec 18Centogene reports Q3 results
Dec 16Centogene and Alnylam launch a clinical screening program targeting rare hereditary disease
Dec 08Centogene expands partnership with PTC Therapeutics in rare genetic disorder
Nov 25Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 60 | -45 | N/A | N/A | 1 |
12/31/2023 | 49 | -49 | N/A | N/A | 1 |
6/30/2023 | 51 | -40 | -29 | -26 | N/A |
3/31/2023 | 49 | -40 | -27 | -24 | N/A |
12/31/2022 | 47 | -39 | -29 | -26 | N/A |
9/30/2022 | -15 | -44 | -29 | -28 | N/A |
6/30/2022 | 2 | -58 | -31 | -29 | N/A |
3/31/2022 | 190 | -44 | -34 | -32 | N/A |
12/31/2021 | 42 | -57 | -27 | -22 | N/A |
9/30/2021 | 162 | -40 | 3 | 13 | N/A |
6/30/2021 | 168 | -24 | 1 | 15 | N/A |
3/31/2021 | 126 | -27 | -5 | 13 | N/A |
1/1/2021 | 38 | -60 | -8 | 8 | N/A |
9/30/2020 | 73 | -30 | -36 | -24 | N/A |
6/30/2020 | 49 | -28 | -31 | -21 | N/A |
3/31/2020 | 50 | -24 | -17 | -9 | N/A |
12/31/2019 | 49 | -21 | -15 | -8 | N/A |
9/30/2019 | 44 | -19 | -13 | -4 | N/A |
6/30/2019 | 45 | -16 | -11 | -3 | N/A |
3/31/2019 | 43 | -13 | -16 | -6 | N/A |
12/31/2018 | 40 | -11 | -16 | -5 | N/A |
9/30/2018 | 39 | -9 | -21 | -4 | N/A |
12/31/2017 | 32 | -5 | -22 | -4 | N/A |
12/31/2016 | 28 | -5 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CNTG is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CNTG is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CNTG is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CNTG's revenue (12.4% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: CNTG's revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CNTG's Return on Equity is forecast to be high in 3 years time